| Product revenue | |
| Research and development revenue | 4.45M |
| Total revenues | 4.45M |
| Cost of goods sold | |
| Research and development | -21.59M |
| General and administrative | -8.11M |
| Operating loss | -36.22M |
| Non-operating income (expense) | -139.64K |
| Interest expense | |
| Interest income | |
| Net loss | -40.77M |
| Dividends on series A convertible preferred stock | |
| Net loss attributable to common stockholders | -40.82M |
| Net loss attributable to common stockholders | |
| Weighted average number of common shares outstanding, basic and diluted | |